NORTH CHICAGO, Ill. , Nov. 9, 2022 /PRNewswire/ — AbbVie (NYSE: ABBV) will participate in the 4 th Annual Wolfe Research Healthcare Conference on Tuesday, November 15, 2022 . Rob Michael , vice chairman and president, Jeffrey R. Stewart , executive vice president, commercial operations, Scott Reents , senior vice chief executive and chief financial officer, and Neil Gallagher , vice leader development plus chief medical officer may present virtually at 10: 30 a. m. Central time .
A live audio webcast of the particular presentation can be accessible through AbbVie’s Investor Relations website at investors. abbvie. com. An archived edition of the session will be available later that day.
AbbVie’s mission is to discover and deliver innovative medicines that will solve serious health issues today plus address the particular medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, and women’s health, in addition to products and services across our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter , Facebook , Instagram , YouTube plus LinkedIn .